| 发明名称 |
THERAPEUTIC USES OF EMPAGLIFLOZIN |
| 摘要 |
The present invention relates to certain SGLT-2 inhibitors for treating and/or preventing metabolic disorders, such as type 1 or type 2 diabetes mellitus or pre-diabetes, in patients with renal impairment or chronic kidney disease (CKD). |
| 申请公布号 |
WO2014161919(A1) |
申请公布日期 |
2014.10.09 |
| 申请号 |
WO2014EP56657 |
申请日期 |
2014.04.03 |
| 申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
发明人 |
BROEDL, ULI;VON EYNATTEN, MAXIMILIAN;MACHA, SREERAJ;WOERLE, HANS-JUERGEN |
| 分类号 |
A61K31/7048;A61P3/10;A61P13/12 |
主分类号 |
A61K31/7048 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
